|   In the News

Disarm Therapeutics brings on former Enzyvant boss Shih as CEO


Disarm Therapeutics has a full-time CEO—the neuro-focused biotech has signed on Alvin Shih, M.D., the former Retrophin R&D chief who went on to helm Enzyvant until February this year.

Read more.